Rosen Law Firm is investigating a class action lawsuit against Disc Medicine, Inc. after the FDA issued a Complete Response Letter rejecting the company's new drug application for bitopertin due to uncertainties requiring more evidence. This announcement caused Disc Medicine's stock price to fall 22% on February 13, 2026. Investors who purchased Disc Medicine securities may be eligible for compensation through a contingency fee arrangement. The Rosen Law Firm is preparing to recover investor losses and encourages affected shareholders to join the class action for potential compensation.
Metaplanet has updated its capital allocation policy to hold 85% to 90% of its assets in Bitcoin, with 10% to 15% allocated to acquisitions and investments that generate recurring income. The company aims to fund most Bitcoin purchases with permanent...
AtlasClear Holdings announced stock option awards for its executive leaders and board members to support long-term retention and align interests with shareholders. The options, granted on October 1, 2026, allow purchase of shares at $0.2010 each and ...
Valor Gold Corp. announced the sudden illness and passing of its CEO, Mark Ashley, a respected leader and mentor. Alan Edwards, the Chairman, will serve as interim CEO, ensuring leadership continuity as the company advances its gold exploration proje...
PEPE meme coin surged to around $0.00000453 on October 5, surpassing the $0.00000445 resistance level after recovering from a recent selloff. Technical analysis suggests a bullish Wolfe Wave pattern that could push PEPE's price to approximately $0.00...
David Borde has been appointed president and CEO of Entergy Texas, effective October 5, 2026, succeeding Eliecer Viamontes who left for other opportunities. Borde has extensive experience in utility strategy, regulatory affairs, and finance, having s...
